Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE…
Event features full Phase 1 data and pivotal Phase 2 strategy for lasme-cel (UCART22) in r/r B-ALL NEW YORK, Oct.…
AMSTERDAM, Oct. 16, 2025 /PRNewswire/ -- Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease…
As regenerative treatments gain traction in the aesthetics industry, Susan Stevens Tanne, M.D. of Plush.MD brings science-based rejuvenation to the…
GUILFORD, SURREY / ACCESS Newswire / October 16, 2025 / ANGLE plc (to be renamed CelLBxHealth plc) (AIM:AGL)(OTCQX:ANPCY), a world-leading…
SAN FRANCISCO, Oct. 15, 2025 /PRNewswire/ -- California based Graph AI, focused on patient safety and pharmacovigilance, announced its $3 million…
In this free webinar, learn ways to identify and relieve site burden throughout the trial lifecycle. Attendees will gain insight…
In this free webinar, gain insight into how ICON Strategic Solutions (ISS) delivers Functional Service Provider (FSP) services that outperform…
SAN DIEGO, CA / ACCESS Newswire / October 15, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a…
KELOWNA, BC / ACCESS Newswire / October 15, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading…